Jasper Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$1.09 | -$1.09 | -$1.09 |
| Q2 2024 | 3 | -$1.07 | -$1.07 | -$1.07 |
| Q3 2024 | 5 | -$1.35 | -$1.11 | -$1.26 |
| Q1 2025 | 2 | -$1.43 | -$1.02 | -$1.23 |
| Q2 2025 | 1 | -$1.30 | -$1.30 | -$1.30 |
| Q3 2025 | 1 | -$1.33 | -$1.33 | -$1.33 |
| Q4 2025 | 1 | -$1.42 | -$1.42 | -$1.42 |
| Q1 2026 | 1 | -$1.02 | -$1.02 | -$1.02 |
| Q2 2026 | 1 | -$1.06 | -$1.06 | -$1.06 |
| Q3 2026 | 1 | -$1.08 | -$1.08 | -$1.08 |
| Q4 2026 | 1 | -$1.12 | -$1.12 | -$1.12 |
Jasper Therapeutics, Inc. Earnings Date And Information
Jasper Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-1.24 earnings per share for the quarter, missing analysts' consensus estimates of $-1.09 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Jasper Therapeutics, Inc. has generated $-6 earnings per share over the last year ($-6.18 diluted earnings per share) and currently has a price-to-earnings ratio of -4.73. Jasper Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Jasper Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.09 | -$1.24 | -0.15 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$1.09 | -$0.97 | 0.12 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$1.26 | -$1.03 | 0.23 | $0 | |
| 03/05/2024 | Q4 2023 | -$1.50 | $2.05 M | |||
| 11/09/2023 | Q3 2023 | -$1.50 | -$1.60 | -0.1 | $0 | |
| 08/11/2023 | Q2 2023 | -$1.30 | -$1.47 | -0.17 | $0 | |
| 05/12/2023 | Q1 2023 | -$1.50 | -$1.80 | -0.3 | $0 | |
| 03/08/2023 | Q4 2022 | -$3.70 | -$3.46 | 0.24 | $0 | |
| 11/10/2022 | Q3 2022 | -$3.50 | -$0.29 | 3.21 | $0 | |
| 08/12/2022 | Q2 2022 | -$2.90 | -$0.24 | 2.66 | $0 | |
| 05/12/2022 | Q1 2022 | -$3.60 | $0.23 | 3.83 | $0 | |
| 03/18/2022 | Q4 2021 | -$0.34 | -$1.82 | -1.48 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.28 | -$0.69 | -0.41 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.22 | $0 | |||
| 07/22/2021 | Q1 2021 | -$0.26 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.26 | $0 | |||
| 11/10/2020 | Q3 2020 | -$0.29 | $0 | |||
| 08/13/2020 | Q2 2020 | -$16.08 | $0 | |||
| 05/13/2020 | Q1 2020 | $0.00 | $0 |
Jasper Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Jasper Therapeutics, Inc.'s earnings date?
Jasper Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
How can I listen to Jasper Therapeutics, Inc.'s earnings conference call?
The conference call for Jasper Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Jasper Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Jasper Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Jasper Therapeutics, Inc. generate each year?
Jasper Therapeutics, Inc. (:JSPR) has a recorded net income of $0. Jasper Therapeutics, Inc. has generated $-6.18 earnings per share over the last four quarters.
-
What is Jasper Therapeutics, Inc.'s price-to-earnings ratio?
Jasper Therapeutics, Inc. (:JSPR) has a price-to-earnings ratio of -4.73 and price/earnings-to-growth ratio is -0.15.
